VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,890 | -12.1% | 11,330 | -1.6% | 0.04% | -10.6% |
| Q2 2023 | $346,867 | -19.5% | 11,520 | -13.5% | 0.05% | -20.3% |
| Q1 2023 | $430,740 | +10.0% | 13,315 | -2.5% | 0.06% | +3.5% |
| Q4 2022 | $391,496 | +35.0% | 13,660 | +13.6% | 0.06% | +23.9% |
| Q3 2022 | $290,000 | -2.7% | 12,020 | +10.6% | 0.05% | +2.2% |
| Q2 2022 | $298,000 | -93.8% | 10,872 | -91.3% | 0.04% | -93.1% |
| Q1 2022 | $4,768,000 | -8.4% | 124,319 | -23.5% | 0.65% | -6.9% |
| Q4 2021 | $5,208,000 | +38.1% | 162,600 | +27.1% | 0.70% | +24.1% |
| Q3 2021 | $3,772,000 | -14.1% | 127,980 | -10.5% | 0.56% | -15.6% |
| Q2 2021 | $4,392,000 | +6.7% | 143,042 | +5.1% | 0.66% | -4.3% |
| Q1 2021 | $4,116,000 | -5.4% | 136,094 | +12.7% | 0.70% | -17.9% |
| Q4 2020 | $4,349,000 | -27.7% | 120,744 | -21.4% | 0.85% | -41.7% |
| Q3 2020 | $6,015,000 | +4.6% | 153,594 | -2.1% | 1.45% | -23.6% |
| Q2 2020 | $5,752,000 | +30.6% | 156,819 | +9.5% | 1.90% | +22.3% |
| Q1 2020 | $4,404,000 | +5.3% | 143,265 | -1.2% | 1.56% | +25.6% |
| Q4 2019 | $4,184,000 | +10.9% | 144,973 | +2.6% | 1.24% | -7.2% |
| Q3 2019 | $3,774,000 | -3.9% | 141,288 | +0.1% | 1.34% | -11.3% |
| Q2 2019 | $3,928,000 | +23.8% | 141,126 | -0.3% | 1.51% | +16.7% |
| Q1 2019 | $3,174,000 | +5.1% | 141,548 | -1.2% | 1.29% | -12.5% |
| Q4 2018 | $3,021,000 | +65.8% | 143,245 | +45.6% | 1.48% | +187.5% |
| Q3 2018 | $1,822,000 | -16.4% | 98,370 | +0.7% | 0.51% | -23.8% |
| Q2 2018 | $2,180,000 | +8.8% | 97,724 | +7.2% | 0.67% | -3.3% |
| Q1 2018 | $2,004,000 | 0.0% | 91,155 | +5.7% | 0.70% | -3.1% |
| Q4 2017 | $2,004,000 | +3.4% | 86,230 | +2.1% | 0.72% | -6.8% |
| Q3 2017 | $1,939,000 | +4.8% | 84,438 | +0.8% | 0.77% | -2.5% |
| Q2 2017 | $1,850,000 | -0.4% | 83,799 | +2.9% | 0.79% | -5.6% |
| Q1 2017 | $1,858,000 | +21.6% | 81,439 | +11.5% | 0.84% | +16.9% |
| Q4 2016 | $1,528,000 | -58.9% | 73,030 | -48.0% | 0.72% | -61.8% |
| Q3 2016 | $3,715,000 | -3.3% | 140,550 | +1.4% | 1.87% | -5.1% |
| Q2 2016 | $3,843,000 | – | 138,673 | – | 1.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |